Pien Huang
Pien Huang is a health reporter on the Science desk. She was NPR's first Reflect America Fellow, working with shows, desks and podcasts to bring more diverse voices to air and online.
She's a former producer for WBUR/NPR's On Point and was a 2018 Environmental Reporting Fellow with The GroundTruth Project at WCAI in Cape Cod, covering the human impact on climate change. As a freelance audio and digital reporter, Huang's stories on the environment, arts and culture have been featured on NPR, the BBC and PRI's The World.
Huang's experiences span categories and continents. She was executive producer of Data Made to Matter, a podcast from the MIT Sloan School of Management, and was also an adjunct instructor in podcasting and audio journalism at Northeastern University. She worked as a project manager for public artist Ralph Helmick to help plan and execute The Founder's Memorial in Abu Dhabi and with Stoltze Design to tell visual stories through graphic design. Huang has traveled with scientists looking for signs of environmental change in Cameroon's frogs, in Panama's plants and in the ocean water off the ice edge of Antarctica. She has a degree in environmental science and public policy from Harvard.
-
In the first congressional hearing on monkeypox, federal officials were criticized for being slow to act, and struggling to apply the lessons of the pandemic to the current outbreak.
-
Congress held its hearing on the federal response to the monkeypox outbreak. That comes as cases — and vaccinations — slow down in the U.S.
-
Dr. Demetre Daskalakis is steering the U.S. monkeypox response. A month into the job, he sees signs of success, but there's still more to be done. -
Data shows that a disproportionate number of people who contract monkeypox are also HIV positive. Researchers are trying to figure out the reason.
-
Rates of new cases are declining in major cities, suggesting public health campaigns are working. But the spread
-
All summer, NPR's Science Desk has been looking at sweat. Humans are covered with millions of sweat glands, but it wasn't always that way. When did humans start to sweat?
-
Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.
-
Missteps and delays have hampered the U.S. effort to vaccinate people against monkeypox. Now state health officials and community members are trying to adapt to a controversial "dose sparing" plan.
-
The U.S. is facing a shortage of the monkeypox vaccine as the outbreak grows rapidly. The White House is pursuing a controversial strategy where each person only gets a fraction of the full dose.
-
The CDC stopped recommending quarantines or test-to-stay in schools. It's part of a relaxation of COVID guidance that acknowledges the virus is here to stay, and that many people have prior immunity.
